Denali Therapeutics OverviewDenali Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for DNLI.
Quarterly EBIT
-$137.36M
↑ 5.65% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$527.36M
↓ 2.36% YoY
Trailing 12 months ending Mar 31, 2026
Denali Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for DNLI.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026